Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.






1510 Delp Drive

Harleysville, PA 19438


Contact: contact@altasciences.com


  • With 25+ years of experience, our specialists design, conduct, analyze, and report on trials across various therapeutic areas for regulatory submissions.

  • With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.

  • Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.

  • As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

  • Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.

  • With over 13,000 drives completed and 10 driving simulators on-site, Altasciences is the ideal full-service provider for your driving simulator clinical trials.

  • As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.

  • With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.

  • Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.

  • Altasciences has the advanced level of clinical expertise required to successfully recruit and conduct clinical trials involving special and patient populations.

  • Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.

  • As part of a complete development program or single study with Altasciences, our research support teams deliver the full array of complementary services needed to complete your projects.

  • Altasciences provides expertise in all clinical pharmacology studies required for regulatory submission across a wide range of therapeutic areas.